Electromed (ELMD) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts ELMD Hot Sheet
Join SI Premium – FREE
Electromed (NASDAQ: ELMD) reported Q1 EPS of $0.03, in-line with the analyst estimate of $0.03. Revenue for the quarter came in at $5.38 million versus the consensus estimate of $5.19 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Electromed, Inc. to Report Q4 Fiscal 2026 Financial Results on August 25, 2026
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
- Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 28c, Raises Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
